ProQR Achieves Successful Defense of New Challenge to its Axiomer™ IP Portfolio

2 months ago

LEIDEN, Netherlands & CAMBRIDGE, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (ProQR), a company dedicated…

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

2 months ago

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market…

Alvotech signs U.S. agreement to expand access for newly approved high-concentration interchangeable biosimilar to Humira® (adalimumab)

2 months ago

Alvotech, in agreement with Teva Pharmaceuticals, has signed an agreement with a strategic partner to bring to the U.S. market…

Vaccinologists Keith Klugman and Shabir Madhi Awarded Sabin’s Prestigious Gold Medal; Infectious Diseases Epidemiologist Nicole Basta Receives Rising Star Award

2 months ago

2024 Albert B. Sabin Gold Medal and 2024 Sabin Rising Star Award Presentations Dr. Keith Klugman (left) and Dr. Shabir…

Amarna Therapeutics announces appointment of Aurelia Caparrós as new Chief Business Officer

2 months ago

Aurelia Caparros Aurelia Caparrós, appointed as new Chief Business Officer of Amarna Therapeutics Leiden, The Netherlands, 19 April 2024 –…

FDA approves Roche’s Alecensa as the first adjuvant treatment for people with ALK-positive early-stage lung cancer

2 months ago

Approval based on Phase III ALINA study showing Alecensa reduced the risk of disease recurrence or death by an unprecedented…

Addex to Present at the Swiss Biotech Day 2024

2 months ago

Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug…

2024 Helen Keller Achievement Awards Ceremony Celebrates Media Inclusion

2 months ago

Filmmaker Shawn Levy and Actor Marilee Talkington Honored as Trailblazers for InclusionLucasfilm Lauded as Leader in Accessible Entertainment LOS ANGELES,…

Histogen Files for Voluntary Chapter 11 Protection to Facilitate Wind-Down, Maximize Share Offering

2 months ago

SAN DIEGO, April 18, 2024 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO, the “Company” or “Histogen”), a drug development company for…

Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024

2 months ago

PRINCETON, N.J., April 18, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced…